1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10831)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22057)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: An ARCAD database analysis
    Journal Article

    Yin, J.; Dawood, S.; Cohen, R.; Meyers, J.; Zalcberg, J.; Yoshino, T.; Seymour, M.; Maughan, T.; Saltz, L.; Van Cutsem, E.; more...
    Therapeutic Advances in Medical Oncology (2021)

    Fulltext@MSK | Save
  • Enfortumab vedotin in advanced urothelial carcinoma - The authors reply
    Correspondence

    Petrylak, D. P.; Powles, T.; Rosenberg, J. E.
    New England Journal of Medicine (2021)

    Fulltext@MSK | Save
  • Acquired resistance to KRAS(G12C) inhibition in cancer
    Journal Article

    Awad, M. M.; Liu, S.; Rybkin, I. I.; Arbour, K. C.; Dilly, J.; Zhu, V. W.; Johnson, M. L.; Heist, R. S.; Patil, T.; Riely, G. J.; more...
    New England Journal of Medicine (2021)

    Fulltext@MSK | Save
  • Evidence generation and reproducibility in cell and gene therapy research: A call to action
    Editorial

    Abou-el-Enein, M.; Angelis, A.; Appelbaum, F. R.; Andrews, N. C.; Bates, S. E.; Bierman, A. S.; Brenner, M. K.; Cavazzana, M.; Caligiuri, M. A.; Clevers, H.; more...
    Molecular Therapy - Methods & Clinical Development (2021)

    Fulltext@MSK | Save
  • Comprehensive molecular profiling of desmoplastic small round cell tumor
    Journal Article

    Slotkin, E. K.; Bowman, A. S.; Levine, M. F.; Dela Cruz, F.; Coutinho, D. F.; Sanchez, G. I.; Rosales, N.; Modak, S.; Tap, W. D.; Gounder, M. M.; more...
    Molecular Cancer Research (2021)

    Fulltext@MSK | Save
  • Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): A phase 1b/2 study
    Journal Article

    Lee, C. H.; Shah, A. Y.; Rasco, D.; Rao, A.; Taylor, M. H.; Di Simone, C.; Hsieh, J. J.; Pinto, A.; Shaffer, D. R.; Girones Sarrio, R.; more...
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • Perspectives in melanoma: Meeting report from the Melanoma Bridge (December 3rd–5th, 2020, Italy)
    Editorial

    Ascierto, P. A.; Blank, C.; Dummer, R.; Ernstoff, M. S.; Ferrone, S.; Fox, B. A.; Gajewski, T. F.; Garbe, C.; Hwu, P.; Kalinski, P.; more...
    Journal of Translational Medicine (2021)

    Fulltext@MSK | Save
  • Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): An open-label, single-arm, multicentre, phase 2 study
    Journal Article

    Balar, A. V.; Kamat, A. M.; Kulkarni, G. S.; Uchio, E. M.; Boormans, J. L.; Roumiguié, M.; Krieger, L. E. M.; Singer, E. A.; Bajorin, D. F.; Grivas, P.; more...
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer
    Guidelines

    Galsky, M. D.; Balar, A. V.; Black, P. C.; Campbell, M. T.; Dykstra, G. S.; Grivas, P.; Gupta, S.; Hoimes, C. J.; Lopez, L. P.; Meeks, J. J.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors
    Guidelines

    Guidon, A. C.; Burton, L. B.; Chwalisz, B. K.; Hillis, J.; Schaller, T. H.; Amato, A. A.; Betof Warner, A.; Brastianos, P. K.; Cho, T. A.; Clardy, S. L.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save